Want to join the conversation?
Janssen Pharmaceuticals, part of $JNJ, and its development partner Bayer HealthCare today declared results from PMSS and XANTUS. The results found the rates and patterns of major bleeding in routine clinical practice were low 2.89 and 2.1 per 100 person-years, respectively and generally consistent with those observed in Phase III clinical research.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?